NCT05315882View on ClinicalTrials.gov

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

March 17, 2020

Study Completion Date

December 17, 2020

Conditions
CMV Infection
Trial Locations (1)

29010

Maria Jesus Pascual, Málaga

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT05315882 - Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA | Biotech Hunter | Biotech Hunter